Cart
sales@molnova.com
CU-CPT-9a
CAS No. 2165340-32-7
CU-CPT-9a( —— )
Catalog No. M20662 CAS No. 2165340-32-7
CU-CPT-9a is a potent TLR8 inhibitor (IC50 : 0.5 nM) that suppresses TLR8-mediated proinflammatory signaling in various cell lines.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 43 | In Stock |
|
| 5MG | 72 | In Stock |
|
| 10MG | 115 | In Stock |
|
| 25MG | 224 | In Stock |
|
| 50MG | 410 | In Stock |
|
| 100MG | 605 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCU-CPT-9a
-
NoteResearch use only, not for human use.
-
Brief DescriptionCU-CPT-9a is a potent TLR8 inhibitor (IC50 : 0.5 nM) that suppresses TLR8-mediated proinflammatory signaling in various cell lines.
-
DescriptionCU-CPT-9a is a potent TLR8 inhibitor (IC50 : 0.5 nM) that suppresses TLR8-mediated proinflammatory signaling in various cell lines and human primary cells.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetTLR
-
RecptorTLR8
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2165340-32-7
-
Formula Weight265.31
-
Molecular FormulaC17H15NO2
-
Purity>98% (HPLC)
-
SolubilityDMSO:150 mg/mL (565.38 mM)
-
SMILESCOc1ccc2c(ccnc2c1)-c1ccc(O)c(C)c1
-
Chemical Name2-Methyl-4-(7-methoxy-4-quinolinyl)phenol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhang S Hu Z Tanji H et al. Small-molecule inhibition of TLR8 through stabilization of its resting state[J]. Nature Chemical Biology 2017 14(1):58-64.
molnova catalog
related products
-
Tomaralimab
Tomaralimab (OPN-305) is a humanized IgG4 monoclonal antibody targeting TLR2, used to study myelodysplastic syndromes (MDS).
-
TLR4-IN-C34
TLR4-IN-C34 is an orally active TLR4 inhibitor and reduces systemic inflammation in models of endotoxemia and necrotizing enterocolitis.
-
CU-CPT-8m
CU-CPT-8m is an toll-like receptor 8 (TLR8) antagonist (IC50 : 67 nM).
